|
Clinical Trials and Observations
Citations 381-390 of 2742 total displayed.
|
Past content
(since May 1998):
|
Twenty-five–year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study
- Rajen Mody, Suwen Li, Douglas C. Dover, Stephen Sallan, Wendy Leisenring, Kevin C. Oeffinger, Yutaka Yasui, Leslie L. Robison, and Joseph P. Neglia
Blood 2008; 111: 5515-5523.
[Abstract]
[Full text]
[PDF]
Borrelia infection and risk of non-Hodgkin lymphoma
- Claudia Schöllkopf, Mads Melbye, Lars Munksgaard, Karin Ekström Smedby, Klaus Rostgaard, Bengt Glimelius, Ellen T. Chang, Göran Roos, Mads Hansen, Hans-Olov Adami, and Henrik Hjalgrim
Blood 2008; 111: 5524-5529.
[Abstract]
[Full text]
[PDF]
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab
- Issa F. Khouri, Peter McLaughlin, Rima M. Saliba, Chitra Hosing, Martin Korbling, Ming S. Lee, L. Jeffrey Medeiros, Luis Fayad, Felipe Samaniego, Amin Alousi, Paolo Anderlini, Daniel Couriel, Marcos de Lima, Sergio Giralt, Sattva S. Neelapu, Naoto T. Ueno, Barry I. Samuels, Fredrick Hagemeister, Larry W. Kwak, and Richard E. Champlin
Blood 2008; 111: 5530-5536.
[Abstract]
[Full text]
[PDF]
Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas
- Iwona Wlodarska, Daan Dierickx, Vera Vanhentenrijk, Katrien Van Roosbroeck, Helena Pospísilová, Francesca Minnei, Gregor Verhoef, José Thomas, Peter Vandenberghe, and Chris De Wolf-Peeters
Blood 2008; 111: 5683-5690.
[Abstract]
[Full text]
[PDF]
Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease
- Allison E. Ashley-Koch, Laine Elliott, Melanie E. Kail, Laura M. De Castro, Jude Jonassaint, Terry L. Jackson, Jennifer Price, Kenneth I. Ataga, Marc C. Levesque, J. Brice Weinberg, Eugene P. Orringer, Ann Collins, Jeffery M. Vance, and Marilyn J. Telen
Blood 2008; 111: 5721-5726.
[Abstract]
[Full text]
[PDF]
Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
- Alessandra Ferrajoli, Bang-Ning Lee, Ellen J. Schlette, Susan M. O'Brien, Hui Gao, Sijin Wen, William G. Wierda, Zeev Estrov, Stefan Faderl, Evan N. Cohen, Changping Li, James M. Reuben, and Michael J. Keating
Blood 2008; 111: 5291-5297.
[Abstract]
[Full text]
[PDF]
Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis
- David Saadoun, Michelle Rosenzwajg, Dan Landau, Jean Charles Piette, David Klatzmann, and Patrice Cacoub
Blood 2008; 111: 5334-5341.
[Abstract]
[Full text]
[PDF]
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents
- Mark A. Crowther and Theodore E. Warkentin
Blood 2008; 111: 4871-4879.
[Abstract]
[Full text]
[PDF]
Development and validation of a predictive model for chemotherapy-associated thrombosis
- Alok A. Khorana, Nicole M. Kuderer, Eva Culakova, Gary H. Lyman, and Charles W. Francis
Blood 2008; 111: 4902-4907.
[Abstract]
[Full text]
[PDF]
Appraisal of immunoglobulin free light chain as a marker of response
- Angela Dispenzieri, Lijun Zhang, Jerry A. Katzmann, Melissa Snyder, Emily Blood, Roberta DeGoey, Kimberly Henderson, Robert A. Kyle, Martin M. Oken, Arthur R. Bradwell, and Philip R. Greipp
Blood 2008; 111: 4908-4915.
[Abstract]
[Full text]
[PDF]
|
|
